Skip to main content
OpenTrials
Completed

NCT Number: NCT04913402

Sufentanil Used by Paramedics to Treat Pain in Acute Trauma

The new competence of paramedics to administer opioid analgesics in acute trauma patients without presence or phone-call consult with an emergency medical doctor will be assessed in this study.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Trauma Injury Accidental Injuries Neurologic Manifestations Pain Pathological Conditions, Signs and Symptoms Signs and Symptoms Wounds and Injuries

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Zdravotnická záchranná služba Karlovarského kraje, p.o.

Karlovy Vary, Carlsbad Region, 360 06, Czechia

About this study

The administration and indication of an opioid analgesics is carried by a medical doctor in most European emergency services. However, trips to majority of less serious traumas are realized by ambulances with paramedic crews without a medical doctor present on site. In this study will be assessed the new competence of paramedics to administer opioid analgesics without presence or phone-call consult with an emergency medical doctor.

This study will address the safety and efficacy of sufentanil administered by the paramedics in the field to patients with acute trauma without any consultation with medical doctors.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • acute trauma with severe pain (VAS/NRS > 4)
  • age > 18 years
  • conscious patient (GCS = 15; alert in AVPU)
  • haemodynamically stable patient (> 100mmHg of systolic blood pressure, > 60/min of heart rate)

Exclusion criteria

  • doctor on site
  • paediatric patient
  • predominantly chronic but not acute pain
  • incomplete documentation
  • other than traumatic reasons for opioid administration (eg. acute coronary syndrome)

Treatment and study plan

Sufentanil administered by paramedics after the phone call consultation of medical doctor.

Other

Administration of sufentanil to patients with acute injury by paramedics only after phone-call consultation of medical doctor.

Sufentanil administered by paramedics based on their competency, without consultation of medical doctor.

Other

Administration of sufentanil to patients with acute injury by paramedics with competency to administer sufentanil without medical doctor consultation.

Primary outcomes

  1. The safety of pain treatment by the paramedics with competence to sufentanil - administration in acute trauma - incidence of apnea

    Time frame: After sufentanil administration up to the handover of the patient to the hospital, up to 60 minutes.

    Measurement of incidence of adverse effects of sufentanil administration in both study groups - apnea - during the period from sufentanil administration (baseline) up to handover of the patient to the hospital (percentage).

  2. The safety of pain treatment by the paramedics with competence to sufentanil - administration in acute trauma - incidence of bradypnoea

    Time frame: After sufentanil administration up to the handover of the patient to the hospital, up to 60 minutes.

    Measurement of incidence of adverse effects of sufentanil administration in both study groups - bradypnoea - is measured during the period from sufentanil administration (baseline) up to handover of the patient to the hospital (percentage).

  3. The safety of pain treatment by the paramedics with competence to sufentanil - administration in acute trauma - incidence of nausea.

    Time frame: After sufentanil administration up to the handover of the patient to the hospital, up to 60 minutes.

    Measurement of incidence of adverse effects of sufentanil administration in both study groups - nausea - is measured during the period from sufentanil administration (baseline) up to handover of the patient to the hospital (percentage).

  4. The safety of pain treatment by the paramedics with competence to sufentanil administration in acute trauma - incidence of bradypnoea.

    Time frame: After sufentanil administration up to the handover of the patient to the hospital, up to 60 minutes.

    Measurement of incidence of adverse effects of sufentanil administration in both study groups - vomiting - is measured during the period from sufentanil administration (baseline) up to handover of the patient to the hospital (percentage).

  5. The efficacy of pain treatment by the paramedics with competence to sufentanil - administration in acute trauma - visual analogue scale.

    Time frame: Before sufentanil administration and at the handover of the patient to the hospital, up to 60 minutes.

    The ten point Visual analogue scale is used to measure the efficacy of pain treatment. The difference of VAS before administration of sufentanil and at the handover at the emergency department is calculated and compared in both groups (in points).

  6. The efficacy of pain treatment by the paramedics with competence to sufentanil -administration in acute trauma - numeric rating scale.

    Time frame: Before sufentanil administration and at the handover of the patient to the hospital, up to 60 minutes.

    The ten point Numeric rating scale (NRS) is used to measure the efficacy of pain treatment. The difference of NRS before administration of sufentanil and at the handover at the emergency department is calculated and compared in both groups (in points).

Secondary outcomes

  1. Dose of administered sufentanil

    Time frame: After sufentanil administration, up to 60 minutes.

    The average dose of administered sufentanil per each case (in micrograms) is reported in both groups.

  2. Incidence of potentiation of analgesia by other analgesics

    Time frame: After sufentanil administration, up to 60 minutes.

    Number of cases of potentiation of analgesia by use of additional analgesics and is reported and compared in both groups (pertcentage).

  3. Types of drugs used for potentiation of analgesia by sufentanil

    Time frame: After sufentanil administration, up to 60 minutes.

    The type and generic name of additional analgesics and is reported and compared in both groups (pertcentage).

  4. The influence on haemodynamic parameters - non invasive blood pressure (BP) -systolic blood pressure

    Time frame: Before sufentanil administration and at the time of the handover in hospital, up to 60 minutes.

    The difference of systolic blood pressure before the administration of sufentanil and at the handover at the emergency department is measured, calculated and compared in both groups. Systolic blood pressure is measured in milimeters of hydrargyrum (mmHg).

  5. The influence on haemodynamic parameters - non invasive blood pressure (BP) - diastolic blood pressure

    Time frame: Before sufentanil administration and at the time of the handover in hospital, up to 60 minutes.

    The difference of diastolic blood pressure before the administration of sufentanil and at the handover at the emergency department is measured, calculated and compared in both groups. Diastolic blood pressure is measured in milimeters of hydrargyrum (mmHg).

  6. The influence on haemodynamic parameters - heart rate (HR)

    Time frame: Before sufentanil administration and at the time of the handover in hospital, up to 60 minutes.

    The difference of heart rate before the administration of sufentanil and at the handover at the emergency department is measured, calculated and compared in both groups. Heart rate is measured as monitored or palpated beats per minute (bpm).

  7. The influence on peripheral oxygen saturation (SpO2)

    Time frame: Before sufentanil administration and at the time of the handover in hospital, up to 60 minutes.

    The difference of SpO2 before the administration of sufentanil and at the handover at the emergency department is measured, calculated and compared in both groups. SpO2 is measured as percentage.

  8. Need for oxygenotherapy

    Time frame: After sufentanil administration up to the handover of the patient to the hospital, up to 60 minutes.

    Measurement of incidence of need for oxygenotherapy is measured during the period from sufentanil administration (baseline) up to handover of the patient to the hospital (percentage).

Sponsors and collaborators

Lead sponsor

Zdravotnicka Zachranna Sluzba Karlovarskeho Kraje, P.O.

Other

Collaborators

  • Charles University, Czech Republic

Registry information

Official study title

The Safety of Administration of Sufentanil by Paramedics to Treat Pain in Acute Trauma in The Prehospital Setting: Observational Study

Important dates

Study start
2020
Primary completion
2021
Study completion
2021
First posted
Jun 4, 2021
Registry last updated
Jun 4, 2021

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.